Objective: To observe the therapeutic effect of acupuncture plus moxibustion of Yongquan (KI 1) in improving stroke patients’ dyskinesia and blood rheology. Methods: 78 cases of stroke patients were treated by acupun...Objective: To observe the therapeutic effect of acupuncture plus moxibustion of Yongquan (KI 1) in improving stroke patients’ dyskinesia and blood rheology. Methods: 78 cases of stroke patients were treated by acupuncture and moxibustion of Yongquan (KI 1), once daily, with 20 days being a therapeutic course. Indexes of whole blood viscosity, plasma viscosity, platelet aggregation rate, packed cell volume and fibrinogen were detected before and after treatment. Changes of the functional activity were assessed using Barthel marking method. Results: After 2 courses of acupuncture treatment, all the above mentioned indexes and functional activity were improved significantly (P<0.05～0.01). Conclusion: Acupuncture and moxibustion of Yongquan (KI 1) has an active effect in improving stroke patients’ dyskinesia and blood rheology.展开更多
AIM: To introduce new applications into the ILCORcardiopulmonary resuscitation(CPR) "chain" sequence.METHODS: Stages of the CPR sequence("chain"): prior to the application of chest massage: assess ...AIM: To introduce new applications into the ILCORcardiopulmonary resuscitation(CPR) "chain" sequence.METHODS: Stages of the CPR sequence("chain"): prior to the application of chest massage: assess the victim's state of consciousness and lung-heart failure;seek help(call 911), or in situations in which it is impossible to start the ILCOR protocol:(1) if the victim is trapped in car crash, overturned car, landslide, massive number of victims or catastrophe; or(2) delayed CPR.During chest compression: Yongquan is simultaneously stimulated by a third rescuer. During defibrillator application: activate K-1 Yongquan through needles before defibrillation. Unsuccessful CPR: "gold standard"for legal clinical death.RESULTS: Implies comparing two hypotheses: Ho(null hypothesis) demonstrates no association between the two variables studied; Ha(alternative hypothesis) implies some degree of relation between them. Difference between the two treatments is observed. If it is greater than the standard error multiplied by a coefficient of security, the difference is significant: Ha will be accepted and Ho rejected. First we will compare CPR without defibrillator(method "A") and K-1 Yongquan method(method "B"), using percentages of representative samples(treatment "A": 6.4% response, treatment "B": 85% response). If │PA- PB│ is greater than the product of 1.96 times the standard error, the difference is significant. Because │PA- PB│ = 0.786 is greater than 0.098, the difference between 0.064 and 0.85 is statistically significant. Thus, we reject Ho and accept Ha as correct. Thus, it is improbable that chance was responsible for this association. This analysis shows that K-1 Yongquan method has a "quality guarantee". Second, we compare defibrillators("A") with K-1 Yongquan method("B")(treatment "A": 48%, treatment "B": 84%, │PA- PB│= 0.36; │PA- PB│ = 0.36 is greater than SE × 1.96 = 0.0148 and also statistically significant, demonstrating again the comparative value of the Yongquan method. CONCLUSION: The Yongquan resuscitation manoeuver is a non-invasive, non-tiring, costless, and easy-toapply procedure that provides a second chance when other options fail.展开更多
目的探讨太冲透刺涌泉配合体针治疗月经性偏头痛(menstrual migraine,MM)的临床疗效。方法选取2017年1月至2018年1月确诊为MM的90例患者,按就诊时间先后随机分组,每组30例。针刺治疗组采用太冲透刺涌泉配合体针治疗,药物治疗组口服盐酸...目的探讨太冲透刺涌泉配合体针治疗月经性偏头痛(menstrual migraine,MM)的临床疗效。方法选取2017年1月至2018年1月确诊为MM的90例患者,按就诊时间先后随机分组,每组30例。针刺治疗组采用太冲透刺涌泉配合体针治疗,药物治疗组口服盐酸氟桂利嗪胶囊,针刺联合药物治疗组在针刺联合体针治疗的同时口服盐酸氟桂利嗪胶囊。比较各组治疗前后头痛总积分、MM患者特异性生活质量问卷(migraine specific quality of life questionnaire,MSQ)评分、血浆降钙素基因相关肽(calcitonin gene-related peptide,CGRP)和5-羟色胺(5-hydroxytryptamine,5-HT)含量,并比较各组临床疗效。结果治疗前,3组患者的头痛积分、MSQ评分、CGRP和5-HT差异无统计学意义(P>0.05);治疗后,3组患者的头痛积分、MSQ评分、CGRP和5-HT均明显降低(P<0.05),且经治疗后的针刺联合药物治疗组各指标水平明显低于针刺治疗组和药物治疗组(P<0.05)。针刺联合药物治疗组的治疗总有效率明显高于针刺治疗组和药物治疗组(P<0.05)。结论太冲透刺涌泉配合体针治疗MM临床疗效显著,能够明显改善患者的头痛症状,提高患者生活质量。展开更多
文摘Objective: To observe the therapeutic effect of acupuncture plus moxibustion of Yongquan (KI 1) in improving stroke patients’ dyskinesia and blood rheology. Methods: 78 cases of stroke patients were treated by acupuncture and moxibustion of Yongquan (KI 1), once daily, with 20 days being a therapeutic course. Indexes of whole blood viscosity, plasma viscosity, platelet aggregation rate, packed cell volume and fibrinogen were detected before and after treatment. Changes of the functional activity were assessed using Barthel marking method. Results: After 2 courses of acupuncture treatment, all the above mentioned indexes and functional activity were improved significantly (P<0.05～0.01). Conclusion: Acupuncture and moxibustion of Yongquan (KI 1) has an active effect in improving stroke patients’ dyskinesia and blood rheology.
文摘AIM: To introduce new applications into the ILCORcardiopulmonary resuscitation(CPR) "chain" sequence.METHODS: Stages of the CPR sequence("chain"): prior to the application of chest massage: assess the victim's state of consciousness and lung-heart failure;seek help(call 911), or in situations in which it is impossible to start the ILCOR protocol:(1) if the victim is trapped in car crash, overturned car, landslide, massive number of victims or catastrophe; or(2) delayed CPR.During chest compression: Yongquan is simultaneously stimulated by a third rescuer. During defibrillator application: activate K-1 Yongquan through needles before defibrillation. Unsuccessful CPR: "gold standard"for legal clinical death.RESULTS: Implies comparing two hypotheses: Ho(null hypothesis) demonstrates no association between the two variables studied; Ha(alternative hypothesis) implies some degree of relation between them. Difference between the two treatments is observed. If it is greater than the standard error multiplied by a coefficient of security, the difference is significant: Ha will be accepted and Ho rejected. First we will compare CPR without defibrillator(method "A") and K-1 Yongquan method(method "B"), using percentages of representative samples(treatment "A": 6.4% response, treatment "B": 85% response). If │PA- PB│ is greater than the product of 1.96 times the standard error, the difference is significant. Because │PA- PB│ = 0.786 is greater than 0.098, the difference between 0.064 and 0.85 is statistically significant. Thus, we reject Ho and accept Ha as correct. Thus, it is improbable that chance was responsible for this association. This analysis shows that K-1 Yongquan method has a "quality guarantee". Second, we compare defibrillators("A") with K-1 Yongquan method("B")(treatment "A": 48%, treatment "B": 84%, │PA- PB│= 0.36; │PA- PB│ = 0.36 is greater than SE × 1.96 = 0.0148 and also statistically significant, demonstrating again the comparative value of the Yongquan method. CONCLUSION: The Yongquan resuscitation manoeuver is a non-invasive, non-tiring, costless, and easy-toapply procedure that provides a second chance when other options fail.
文摘目的探讨太冲透刺涌泉配合体针治疗月经性偏头痛(menstrual migraine,MM)的临床疗效。方法选取2017年1月至2018年1月确诊为MM的90例患者,按就诊时间先后随机分组,每组30例。针刺治疗组采用太冲透刺涌泉配合体针治疗,药物治疗组口服盐酸氟桂利嗪胶囊,针刺联合药物治疗组在针刺联合体针治疗的同时口服盐酸氟桂利嗪胶囊。比较各组治疗前后头痛总积分、MM患者特异性生活质量问卷(migraine specific quality of life questionnaire,MSQ)评分、血浆降钙素基因相关肽(calcitonin gene-related peptide,CGRP)和5-羟色胺(5-hydroxytryptamine,5-HT)含量,并比较各组临床疗效。结果治疗前,3组患者的头痛积分、MSQ评分、CGRP和5-HT差异无统计学意义(P>0.05);治疗后,3组患者的头痛积分、MSQ评分、CGRP和5-HT均明显降低(P<0.05),且经治疗后的针刺联合药物治疗组各指标水平明显低于针刺治疗组和药物治疗组(P<0.05)。针刺联合药物治疗组的治疗总有效率明显高于针刺治疗组和药物治疗组(P<0.05)。结论太冲透刺涌泉配合体针治疗MM临床疗效显著,能够明显改善患者的头痛症状,提高患者生活质量。
